Transfusion-Transmitted Hepatitis E Virus Infection in France

Autor: Jacques Izopet, Elodie Pouchol, Sylvie Gross, Vincent Mallet, Anne-Marie Roque-Afonso, Nassim Kamar, Sébastien Lhomme, Rachid Djoudi, Azzedine Assal, Philippe Bierling, Lina Mouna, Pierre Gallian, Pierre Tiberghien

Publikováno v: Transfusion Medicine Reviews
Transfusion Medicine Reviews, 2019, 33 (3), pp.146-153. ⟨10.1016/j.tmrv.2019.06.001⟩
Transfusion Medicine Reviews, WB Saunders, 2019, ⟨10.1016/j.tmrv.2019.06.001⟩

International audience; There is growing concern regarding the risk of transfusion- transmitted (TT) hepatitis E. Since the first described case in 2006, several TT hepatitis E have been reported to the French hemovigilance network. We performed a re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d57f5e6ff5366564ec63210907258c
https://doi.org/10.1016/j.tmrv.2019.06.001

The prevalence of human T‐lymphotropic virus type 1 & 2 (HTLV‐1/2) in South African blood donors

Autor: Ravi Reddy, Edward L. Murphy, Jabulisile Jaza, Olivier Cassar, Antoine Gessain, Charlotte Ingram, Marion Vermeulen, Charl Coleman, Colwyn Poole, Genevieve Jacobs, Wendy Sykes, Brian Custer, Zhanna Kaidarova, Carol Hlela

Publikováno v: Vox Sanguinis
Vox Sanguinis, Wiley, 2019, 114 (5), pp.451-458. ⟨10.1111/vox.12778⟩
Vox sanguinis, vol 114, iss 5
Vox Sang
Vermeulen, Marion; Sykes, Wendy; Coleman, Charl; Custer, Brian; Jacobs, Genevieve; Jaza, Jabulisile; et al.(2019). The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.. Vox sanguinis. doi: 10.1111/vox.12778. UCSF: Retrieved from: http://www.escholarship.org/uc/item/7582w44x
Vox Sanguinis, 2019, 114 (5), pp.451-458. ⟨10.1111/vox.12778⟩

Author(s): Vermeulen, Marion; Sykes, Wendy; Coleman, Charl; Custer, Brian; Jacobs, Genevieve; Jaza, Jabulisile; Kaidarova, Zhanna; Hlela, Carol; Gessain, Antoine; Cassar, Olivier; Poole, Colwyn; Ingram, Charlotte; Murphy, Edward L; Reddy, Ravi | Abst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c581e1ce940ab3f5ecf6cea7c07fe4f
https://hal-pasteur.archives-ouvertes.fr/pasteur-03208040/document

Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil

Autor: Virginie Sauvage, Svetoslav Nanev Slavov, Evandra Straza Rodrigues, Cristiane Fração Diefenbach, Simone Kashima, Syria Laperche, Dimas Tadeu Covas, Valérie Caro, Ana Maria Zimmermann

Publikováno v: Journal of Medical Virology
Journal of Medical Virology, 2019, 91 (7), pp.1224-1231. ⟨10.1002/jmv.25453⟩
Journal of Medical Virology, Wiley-Blackwell, 2019, 91 (7), pp.1224-1231. ⟨10.1002/jmv.25453⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

International audience; Usually transmitted via respiratory droplets, parvovirus B19 (B19V) can also be acquired by blood transfusion especially because of viral persistence, resistance to blood treatment procedures, and high viral load during the ea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8593d8ae8bae55c8b511c5f46a1abd12
https://hal-pasteur.archives-ouvertes.fr/pasteur-02921793

Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors

Autor: Pascal Morel, Xavier de Lamballerie, Boris Pastorino, Laetitia Ninove, Pierre Gallian, Jacques Chiaroni

Publikováno v: Antiviral Research
Antiviral Research, Elsevier Masson, 2020, 181, pp.104880. ⟨10.1016/j.antiviral.2020.104880⟩
Antiviral Research, 2020, 181, pp.104880. ⟨10.1016/j.antiviral.2020.104880⟩

We investigated the distribution of antibodies neutralizing SARS-CoV-2 according to age, sex or blood group in French blood donors. In 464 samples collected before the emergence of SARS-CoV-2 (2017 and 2018), our virus neutralization assay had a 100%

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b34d61c58a9c60d3995c6a4d1cdd2f65
https://doi.org/10.1016/j.antiviral.2020.104880

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study

Autor: Harr Freeya Njai, Ramou Njie, Gibril Ndow, Aboubacar Kambi, Maimuna Mendy, Isabelle Chemin, Tumani Corrah, Saydiba Tamba, Maud Lemoine, Adam Jeng, Louise Sarr, Souleymane Mboup, Shevanthi Nayagam, Mark Thursz, Hilton Whittle, Jessica Howell, Penda Suso, Makie Taal, Amina Sow, Liliane Mpabanzi, Simon D. Taylor-Robinson, Yusuke Shimakawa, Ousman Nyan, William Stanger, Coumba Toure-Kane, Saunab Ghosh, Abdullah Jatta, Umberto D'Alessandro

Publikováno v: The Lancet global health
The Lancet global health, Elsevier, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
The Lancet Global Health, Vol 4, Iss 8, Pp e559-e567 (2016)
The Lancet global health, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
e567
e559

Comment in : Screen-and-treat for chronic hepatitis B: an overdue issue for sub-Saharan Africa./Allain JP. Lancet Glob Health. 2016 Aug;4(8):e507-8. doi: 10.1016/S2214-109X(16)30140-1. PMID: 27443770; International audience; Background: Despite the i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce96b12b42eac91dfb0ac53ad6b8113
https://hal-pasteur.archives-ouvertes.fr/pasteur-02875279/file/1-s2.0-S2214109X16301309-main.pdf